Bernard Fromenty

15.3k total citations · 5 hit papers
154 papers, 11.8k citations indexed

About

Bernard Fromenty is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Bernard Fromenty has authored 154 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Epidemiology, 60 papers in Molecular Biology and 41 papers in Pharmacology. Recurrent topics in Bernard Fromenty's work include Liver Disease Diagnosis and Treatment (73 papers), Drug-Induced Hepatotoxicity and Protection (35 papers) and Metabolism and Genetic Disorders (34 papers). Bernard Fromenty is often cited by papers focused on Liver Disease Diagnosis and Treatment (73 papers), Drug-Induced Hepatotoxicity and Protection (35 papers) and Metabolism and Genetic Disorders (34 papers). Bernard Fromenty collaborates with scholars based in France, United States and United Kingdom. Bernard Fromenty's co-authors include Dominique Pessayre, Abdellah Mansouri, Karima Begriche, Alain Berson, Marie‐Anne Robin, Julie Massart, Philippe Lettéron, Anissa Igoudjil, Gilles Labbe and Claude Degott and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Bernard Fromenty

150 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

2006 606 citations Karima Begriche, Dominique Pessayre et al. profile →
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

1995 512 citations Bernard Fromenty et al. profile →
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease

2013 467 citations Karima Begriche, Julie Massart et al. Hepatology profile →
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver

2010 404 citations Karima Begriche, Julie Massart et al. Journal of Hepatology profile →
Mitochondrial alterations in fatty liver diseases

2022 215 citations Bernard Fromenty et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Bernard Fromenty

Since Specialization

Citations

This map shows the geographic impact of Bernard Fromenty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Fromenty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Fromenty more than expected).

Fields of papers citing papers by Bernard Fromenty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Fromenty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Fromenty. The network helps show where Bernard Fromenty may publish in the future.

Co-authorship network of co-authors of Bernard Fromenty

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Fromenty. A scholar is included among the top collaborators of Bernard Fromenty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Fromenty. Bernard Fromenty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas 2025 ·Cell Death and Disease ·(unknown), Claudine Rauch, (unknown), (unknown), Tifenn Le Charpentier, (unknown), Luis Cano, Daniel Catheline, (unknown), Agnès Burel, (unknown), Catherine Ribault, Claude Bendavid, Bruno Clément, Caroline Aninat, Vincent Rioux, Orlando Musso, Bernard Fromenty, Florian Cabillic, Anne Corlu	0
2	Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals 2024 ·Toxicological Sciences ·Nelly Buron, Mathieu Porceddu, (unknown), Cécile Martel, Julien Allard, Bernard Fromenty, Annie Borgne‐Sanchez	2
3	Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach 2024 ·Toxicology and Applied Pharmacology ·Claire Beausoleil, Anne Thébault, Patrik L. Andersson, (unknown), Sibylle Ermler, Bernard Fromenty, (unknown), Julian L. Griffin, Sebastian Hoffmann, Jorke H. Kamstra, (unknown), Virissa Lenters, Vesna Munić Kos, Nathalie Poupin, Sylvie Rémy, (unknown), Daniel Zalko, Juliette Legler, Miriam N. Jacobs, Christophe Rousselle	6
4	Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug‐induced liver injury 2023 ·Fundamental and Clinical Pharmacology ·(unknown), Simon Bucher, Pierre‐Jean Ferron, (unknown), Bernard Fromenty	2
5	Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients 2021 ·International Journal of Molecular Sciences ·Pierre‐Jean Ferron, Brendan Le Daré, (unknown), Clara Steichen, (unknown), Romain Pelletier, Thierry Hauet, Isabelle Morel, Karin Tarte, Florian Reizine, Bruno Clément, Bernard Fromenty, Thomas Gicquel	11
6	Fatal acetaminophen poisoning with hepatic microvesicular steatosis in a child after repeated administration of therapeutic doses 2020 ·Forensic Science International ·Renaud Bouvet, (unknown), (unknown), Bernard Fromenty, Isabelle Morel, Bruno Turlin, Thomas Gicquel	9
7	Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and Chemoresistance 2019 ·Cancer Research ·(unknown), Hélène Dubois‐Pot‐Schneider, Romain Désert, (unknown), Denise Glaise, Claudine Rauch, Fabrice Morel, Bernard Fromenty, Orlando Musso, Florian Cabillic, Anne Corlu	52
8	Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Dounia Le Guillou, Simon Bucher, Karima Begriche, (unknown), Anne Lombès, Gilles Labbe, Bernard Fromenty	28
9	Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease 2015 ·Journal of Clinical Investigation ·Géraldine Gentric, (unknown), Valérie Paradis, Dominique Couton, Antoine L’Hermitte, Ganna Panasyuk, Bernard Fromenty, Séverine Celton‐Morizur, Chantal Desdouets	175
10	Drug-induced liver injury in obesity 2013 ·Journal of Hepatology ·Bernard Fromenty	69
11	Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis 2011 ·British Journal of Pharmacology ·Julie Massart, MA Robin, (unknown), Alain Fautrel, P Lettéron, André Bado, Pierre‐Antoine Eliat, Bernard Fromenty	31
12	Central role of mitochondria in drug-induced liver injury 2011 ·Drug Metabolism Reviews ·Dominique Pessayre, Bernard Fromenty, Alain Berson, Marie‐Anne Robin, Philippe Lettéron, Richard Moreau, Abdellah Mansouri	201
13	Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease 2010 ·Laboratory Investigation ·Claudia Mitchell, Meriem Mahrouf‐Yorgov, Alicia Mayeuf-Louchart, Marie‐Anne Robin, Abdellah Mansouri, Bernard Fromenty, Hélène Gilgenkrantz	23
14	Chronic Ethanol Consumption Lessens the Gain of Body Weight, Liver Triglycerides, and Diabetes in Obese ob/ob Mice 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Bernard Fromenty, Nathalie Vadrot, Julie Massart, Bruno Turlin, Nadège Barri‐Ova, Philippe Lettéron, Alain Fautrel, Marie‐Anne Robin	41
15	[721] OVEREXPRESSION OF MANGANESE SUPEROXIDE DISMUTASE TRIGGERS MITOCHONDRIA!. DAMAGE AFTER CHRONIC ALCOHOL INTOXICATION IN MOUSE LIVER 2007 ·Journal of Hepatology ·(unknown), P Lettéron, Bernard Fromenty, Adjé Abbey‐Toby, Nathalie Vadrot, Georg Feldmann, Holly Van Remmen, Alan Richardson, Dominique Pessayre, Abdellah Mansouri	1
16	Alcohol increases tumor necrosis factor α and decreases nuclear factor‐κb to activate hepatic apoptosis in genetically obese mice† 2005 ·Hepatology ·Marie‐Anne Robin, Christine Demeilliers, Angéla Sutton, Valérie Paradis, (unknown), Sylvie Dubois, Odile Poirel, Philippe Lettéron, Dominique Pessayre, Bernard Fromenty	66
17	Mitochondrial injury in steatohepatitis 2004 ·European Journal of Gastroenterology & Hepatology ·Dominique Pessayre, Bernard Fromenty, Abdellah Mansouri	129
18	Fulminant Hepatitis After Grand Mal Seizures: Mechanisms and Role of Liver Transplantation 2003 ·Hepatology ·Philippe Ichaı̈, Emmanuel Huguet, Catherine Guettier, Daniel Azoulay, (unknown), Bernard Fromenty, P. Masnou, Faouzi Saliba, Bruno Roche, (unknown), Denis Castaing, Didier Samuel	9
19	Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction 1996 ·Gastroenterology ·Alain Berson, Sylvaine Renault, P Lettéron, MA Robin, Bernard Fromenty, Daniel Fau, (unknown), C. Riché, (unknown), Gérard Feldmann, Dominique Pessayre	60
20	Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions 1994 ·Hepatology ·D Deschamps, (unknown), C Fisch, Bernard Fromenty, André Guillouzo, Dominique Pessayre	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact